Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. - Wikidata - awgldk - TriplyDB

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.

http://www.wikidata.org/entity/Q40783492

about

Bone marrow-derived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction The Evolution of the Stem Cell Theory for Heart Failure Gene and cell therapies for the failing heart to prevent sudden arrhythmic death Stem cell therapy for chronic heart failure: an updated appraisal Bone marrow mononuclear cells and acute myocardial infarction Cell-based interventions for therapeutic angiogenesis: review of potential cell sources Stem cell therapy for critical limb ischemia: what can we learn from cell therapy for chronic wounds?Bone marrow stem cell transplantation for cardiac repair Paracrine mechanisms in adult stem cell signaling and therapy Biohybrid cochlear implants in human neurosensory restoration.Microbubble destruction with ultrasound augments neovascularisation by bone marrow cell transplantation in rat hind limb ischaemia.Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms.Local injection of autologous bone marrow cells to regenerate muscle in patients with traumatic brachial plexus injury: a pilot study.Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells.Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4.Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheres Cardiomyocyte regeneration from circulating bone marrow cells in mice.Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia.No evidence of myocardial restoration following transplantation of mononuclear bone marrow cells in coronary bypass grafting surgery patients based upon cardiac SPECT and 18F-PET Cell therapy in congestive heart failure.Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats.Intracoronary autologous bone marrow-derived mononuclear cell transplantation improves coronary collateral vessel formation and recruitment capacity in patients with ischemic cardiomyopathy: a combined hemodynamic and scintigraphic approach.Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium.Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction.Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia.A role of myocardial stiffness in cell-based cardiac repair: a hypothesis.Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial.Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells.Cell therapy for myocardial infarction.Myocardial survival signaling in response to stem cell transplantation.Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.PPARalpha is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis Stem cell paracrine actions and tissue regeneration.Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products.Aesthetic cardiology: adipose-derived stem cells for myocardial repair.

P2860

Q24305175-C371EFDF-7D66-4E4C-A6B5-AA50B3D04984 Q24314350-C000C70B-0607-4137-A81D-40BA67477448 Q26769042-EB578F59-3D0F-40CF-B9BD-002B066A914E Q26865425-6CF88465-71F5-4671-AD64-D953DB3262B8 Q26866170-88D46B17-D226-4D5A-AB5A-11DB60394A26 Q27006710-3E5A6F31-5A0E-462B-8521-D33E8656C446 Q27022590-9B480ED5-C9D3-45F3-AB4E-3BF2D0FE3630 Q27022877-56BCF3EF-5805-4B9B-A936-0EB46E30DB6D Q28251098-42E70060-F75B-42B9-8EF4-AEBF4971D104 Q29620571-A0530BF8-EB2C-4894-997F-B8799973F344 Q30372209-6D86F0FB-329C-4162-B60F-8AF61D693B33 Q30490368-F5E457F0-6C9A-4092-B252-2897D5198ED2 Q30557136-D504D570-D4E2-4C6C-B0DA-B97C17101E3D Q30573375-DA8CE27C-104E-49E9-B0D0-71F7320A9576 Q30826734-1C609380-D699-4E29-A1B5-B7D2559EBA2F Q30888146-911E159A-64BA-4970-B0E4-8F2CEFEE475E Q31039862-B83C5722-7303-4F26-BCEE-E321F0CE8529 Q31058133-9F579A54-35CF-4BD2-81B8-5EBEBEC7BAB6 Q31148531-8D0CA7AF-FE73-468E-9893-2B2C66A59D0D Q33247535-95DE2249-9CC7-469D-8CBB-AF9E6078FA7E Q33250264-5497F7C6-276B-4CC4-B22B-A2E3183DC5CE Q33295408-D2966642-8F73-4994-A14A-9B4FF5DAF120 Q33304571-E9E807A9-BF11-4F3A-A1D1-C636DBE80A60 Q33327638-788A4159-D1A9-43A2-814A-C0B7C7284832 Q33330259-0AB974FD-AD40-4F5C-AD82-B50327C1A7E7 Q33379564-EE74ADB4-83D3-46B7-89CF-572A4B396E27 Q33388920-FBB9AE39-3044-4D41-862B-9424F5D76AED Q33412550-D32BC77C-7DBF-41CD-9BC0-146C9A2B3AF6 Q33433387-680C5E85-41D5-4144-B67E-DAAEF502C85E Q33462060-78CC7A50-DCED-4736-A312-92338457CDB5 Q33505911-383C17A1-EC9A-4FD6-8974-CBE6C529010A Q33532670-00D75B7A-8CF6-43C2-9683-E58E9FC1CD75 Q33618626-EF98585C-05EF-4298-B0BB-60EBCDB66394 Q33635730-45C57307-6609-42E8-BC56-5A46C9EC5781 Q33648557-1C70E89F-229D-4ACB-9F61-E037653C2759 Q33682146-CDA22F2E-3A58-47AC-8CE3-C3B129CDF26B Q33708216-252AE69D-B877-41BC-959B-F729F3F68015 Q33777861-1FE00376-B80D-4AFD-8AEF-1575B75C7F26 Q33942087-F04AE237-007C-45B8-A5E4-A48DB3E8B79A Q33957120-39D18080-6D5B-4F83-97A8-1B67B67247FF

P2860

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.

http://www.wikidata.org/entity/Q40783492

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Implantation of bone marrow mo ...... ogenic ligands, and cytokines.

@en

type

label

Implantation of bone marrow mo ...... ogenic ligands, and cytokines.

@en

prefLabel

Implantation of bone marrow mo ...... ogenic ligands, and cytokines.

@en

P1433

Q40783492-050721D5-A0B8-40F8-95D0-F5F635861363

P1476

Q40783492-47821137-2C2F-4AEB-9B5D-8FE85F6ADCE8

P2093

Q40783492-0A494DB6-179B-4F3B-9155-4A5D13C587CF

Q40783492-0BC33E64-FBB7-4262-BFDA-BD16C85CBE05

Q40783492-16551C30-325B-4369-A51D-DC2D58FA34FD

Q40783492-46CBFECD-2F37-42F0-A6DC-9FB665343A9C

Q40783492-4EB4C449-B775-452C-8456-33822977095C

Q40783492-542C3464-8FD7-44C3-98DB-A5C8DC060C55

Q40783492-55CDD831-20B7-4EC4-BEB5-A63D9B4DD03F

Q40783492-6C600B63-51D9-4ADD-B550-9C9A1230091C

Q40783492-84E1C684-144B-4127-B9F4-2DBC9CA56454

Q40783492-858F93DE-10AE-4F81-8893-7B2E80BC0C38

P304

Q40783492-F871A038-FAD0-457D-8D7D-53DB4DBF622F

P31

Q40783492-84E92E0C-7259-4653-8FBC-C2581A64B83E

P356

Q40783492-B4FCB7BC-197F-48BE-87A6-818E827C04C4

P407

Q40783492-1EE4009D-C900-4E78-995D-B8050FFDAB35

P433

Q40783492-244ECCC3-67D3-48A8-8860-92F49AF7629A

P478

Q40783492-3F852802-35C3-4964-90D9-06D792B61D60

P577

Q40783492-A46E35E2-726C-47B1-AA71-25A73C426EEA

P5875

Q40783492-AC4CE3B4-0620-43FB-9D0D-539370A22A34

P698

Q40783492-664A6074-A714-4AC5-A0CA-2DDF5F873EB5

P356

P1433

P1476

Implantation of bone marrow mo ...... ogenic ligands, and cytokines.

@en

P2093

Fujiyama S

http://www.w3.org/2001/XMLSchema#string

Iba O

http://www.w3.org/2001/XMLSchema#string

Imaizumi T

http://www.w3.org/2001/XMLSchema#string

Iwasaka T

http://www.w3.org/2001/XMLSchema#string

Kamihata H

http://www.w3.org/2001/XMLSchema#string

Kosaki A

http://www.w3.org/2001/XMLSchema#string

Masaki H

http://www.w3.org/2001/XMLSchema#string

Matsubara H

http://www.w3.org/2001/XMLSchema#string

Mori Y

http://www.w3.org/2001/XMLSchema#string

Murohara T

http://www.w3.org/2001/XMLSchema#string

P304

1046-1052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HC3501.093817

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11822241

http://www.w3.org/2001/XMLSchema#string

P698

11524400

http://www.w3.org/2001/XMLSchema#string